The U.S. Postal Service began to allow inbound mail and packages from China and Hong Kong Posts on Wednesday, less than 24 ...

Health officials in Northern New York have issued a warning after reporting the "highest number" of overdoses in a single month, back in January ...

Authorities arrested a 70-year-old Carrollton man last week after uncovering an illegal opioid distribution operation from ...

The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

While New Orleans prepares for the excitement of the big game, it’s important to remember that sports injuries aren’t limited to the professionals. High school athletes, weekend warriors, and generall ...

The United States Postal Service announced on Tuesday it will temporarily suspend international package acceptance of inbound ...

The amount of women who were diagnosed with a substance use disorder in Ohio when they delivered their babies has increased over the years, but are the resources in our communities available to help ...

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...

School district employees who administer the emergency antagonists in compliance with state law are immune from civil liability. CDC data points out that while overall fentanyl overdoses in the U.S.

Adolore BioTherapeutics (”Adolore” or the “Company”), is developing intracellularly-delivered neuromodulators that naturally reduce neuronal excitability to restore balance to the PNS/CNS to treat the ...

More New Yorkers received scripts for buprenorphine, a med used to treat opioid addiction, amid fight against record-high ...

Federal officials have approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S.